Overview


According to FutureWise analysis, the market for allergy treatment in 2023 is US$ 21.64 billion, and is expected to reach US$ 24.78 billion by 2031 at a CAGR of 7.10%.

Allergies are a common health issue where the immune system reacts abnormall to an allergen substance. These allergens are of various forms, such as pollen, dust mites, pet dander, certain foods, or medications. When exposed to these allergens, individuals may experience symptoms like sneezing, itching, watery eyes, or skin rashes. According to the World Allergy Organization, approximately 30-40% of the global population suffers from allergies. 

The allergy treatment market refers to the industry that develops and provides solutions for individuals suffering from allergies. The market offers multiple treatments, including medications, immunotherapy, and lifestyle modifications. Medicines play a crucial role in allergy treatment. Antihistamines, nasal corticosteroids, decongestants, and eye drops manage allergy symptoms by reducing inflammation and blocking the release of histamine, a chemical that triggers allergic reactions. With advancements in pharmaceutical research, new and improved allergy medications are regularly introduced. Immunotherapy, also known as allergy shots, is another vital segment of the allergy treatment market. This treatment involves exposing individuals to small amounts of allergens over time, gradually desensitizing their immune system and reducing allergic reactions. It offers long-term relief and can significantly improve the quality of life. These respiratory allergies are among the most common types worldwide and can significantly impact an individual's quality of life. As a result, there is a strong demand for effective treatments to manage these conditions, contributing to market growth. 

FutureWise Market Research has published a report that provides an insightful analysis of allergy treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes the stature of key manufacturers operating in this industry. According to the analysis conducted by FutureWise research analysts, the allergy treatment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition to providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organization to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • GlaxoSmithKline
  • ALK-Abelló A/S
  • Sallergenes Greer
  • Allergy Therapeutics
  • Sanofi SA
  • Johnson and Johnson
  • Merck Co. In
  • Merck KGaA
  • F. Hoffmann-La Roche AG
  • Allergan plc.
  • Stallergenes Greer plc
  • Leti Pharma
  • Novartis AG
  • Cipla Inc
  • Aurobindo Pharma

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments by the key market players in the Allergy Treatment Market:

  • In August 2022, an affiliate of Glenmark Pharmaceuticals introduced the sole authorized fixed-dose combination treatment for seasonal allergic rhinitis within the market of the United States.

Several key factors are currently driving the allergy treatment market, such as the growing prevalence of allergies worldwide, with more and more individuals being diagnosed with various types of allergies has created a significant demand for effective allergy treatments, driving the market's growth. With advancements in medical research and technology, allergies can now be treated more effectively through innovative approaches like immunotherapy and personalized therapies. The effectiveness of new allergy treatments in managing symptoms and improving patients' quality of life has led to increased adoption rates and market growth. Healthcare providers and the general public are becoming more aware and knowledgeable about allergies, contributing to this positive trend. With better knowledge about the causes, symptoms, and treatment options for allergies, more individuals seek medical help and appropriate treatments, creating a more extensive customer base for allergy treatment providers and contributing to market growth. Furthermore, the rising healthcare expenditure in both developed and developing countries is fuelling the development of the allergy treatment market. As individuals become more conscious about their health and well-being, they are willing to spend more on effective allergy treatments, which has led to increased research and development expenditure by pharmaceutical companies to develop new and improved allergy treatments, further driving the market growth. However, one primary constraint is the high cost of allergy treatments. Allergy treatments can be expensive, especially for individuals who require long-term or ongoing treatment, which makes it difficult for some patients to afford the necessary medications or therapies. Furthermore, the regulatory landscape can also restrain the allergy treatment market. The approval process for new allergy treatments can be lengthy and complex, requiring extensive clinical trials and safety evaluation, delaying the introduction of new and potentially more effective therapies into the market, and limiting the options available to patients. During the forecast period, these factors are expected to limit market growth.

By Type

  • Eye Allergy
  • Skin Allergy
  • Food Allergy
  • Asthma
  • Rhinitis
  • Others

By Treatment

  • Anti-Allergy Drugs
    • Antihistamines
    • Corticosteroids
    • Decongestants
    • Other Drugs
  • Immunotherapy
    • Sub-cutaneous Immunotherapy (SCIT)
    • Sub-Lingual Immunotherapy (SLIT)

By Dosage Form

  • Oral
  • Inhalers
  • Intranasal
  • Others

By Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Retailers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasizes factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market which is based on the conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is one of the largest markets for allergic treatments. The United States, in particular, has a significant prevalence of allergic rhinitis, driving market demand in this region. Factors such as a well-established healthcare system, advanced medical infrastructure, and high awareness about allergies contribute to the growth of the allergic rhinitis market in North America. Europe is another prominent market for allergic rhinitis treatments. Nations like Germany, France, and the United Kingdom have a considerable patient population suffering from allergic rhinitis. The presence of major pharmaceutical companies, intense research and development capabilities, and well-developed healthcare systems contribute to the market growth in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Allergy Treatment Market By Type, By Treatment, By Dosage Form, By Distribution Channels and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Allergy Treatment Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Allergy Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Allergy Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Allergy Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Eye Allergy
        2. Skin Allergy
        3. Food Allergy
        4. Asthma
        5. Rhinitis
        6. Others

  • 8.   Allergy Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Anti-Allergy Drugs
         1.1. Antihistamines
         1.2. Corticosteroids
         1.3. Decongestants
         1.4. Other Drugs
        2. Immunotherapy
         2.1. Sub-cutaneous Immunotherapy (SCIT)
         2.2. Sub-Lingual Immunotherapy (SLIT)

  • 9.   Allergy Treatment Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Oral
        2. Inhalers
        3. Intranasal
        4. Others

  • 10.   Allergy Treatment Market, By Distribution Channels Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Retailers
        4. Others

  • 11.   North America Allergy Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Allergy Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Allergy Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Allergy Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. GlaxoSmithKline
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ALK-Abelló A/S
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Sallergenes Greer
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Allergy Therapeutics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi SA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Johnson and Johnson
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Merck Co. In
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Merck KGaA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. F. Hoffmann-La Roche AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Allergan plc.
         10.1.Company Overview
         10.2.Product Portfolio
         10.3.SWOT Analysis
         10.4.Financial Overview
         10.5.Strategic Overview
        11. Stallergenes Greer plc
         11.1.Company Overview
         11.2.Product Portfolio
         11.3.SWOT Analysis
         11.4.Financial Overview
         11.5.Strategic Overview
        12. Leti Pharma
         12.1.Company Overview
         12.2.Product Portfolio
         12.3.SWOT Analysis
         12.4.Financial Overview
         12.5.Strategic Overview
        13. Novartis AG
         13.1.Company Overview
         13.2.Product Portfolio
         13.3.SWOT Analysis
         13.4.Financial Overview
         13.5.Strategic Overview
        14. Cipla Inc
         14.1.Company Overview
         14.2.Product Portfolio
         14.3.SWOT Analysis
         14.4.Financial Overview
         14.5.Strategic Overview
        15. Aurobindo Pharma
         15.1.Company Overview
         15.2.Product Portfolio
         15.3.SWOT Analysis
         15.4.Financial Overview
         15.5.Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11